P. Fumoleau

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

G. Peters, G. Giaccone, J. Wanders, 2003, Cancer Chemotherapy and Pharmacology.

Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer-results of a first-in-man dose-escalation study with a fixed-dose extension phase.

J. Soria, P. Fumoleau, A. Hollebecque, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation.

J. Wanders, E. Raymond, J. Beijnen, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.